Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04715711 · ClinicalTrials.gov registry record · NA

Physiological and Thermoregulatory Responses of Body Cooling During Cycling in a Hot Environment

A NA study of Hyperthermia, sponsored by University of Connecticut.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT04715711: Completed NA study of Hyperthermia, sponsored by University of Connecticut.

NCT04715711 is a NA study of Hyperthermia that has completed, run by University of Connecticut. The registered enrollment target is 12 participants, below the 49-participant average among 15 other Hyperthermia trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04715711, a NA study of Hyperthermia, has completed, sponsored by University of Connecticut.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

BHSAI is developing a computational system that provides early alerts of a rise in core body temperature to help reduce the risk of heat injury in the field and during training. The goal of the body temperature alerting system is to use it during rest, exercise in the heat and during body cooling. Using this system during cooling will allow healthcare professionals and military personnel monitor core temperature to ensure cooling is effective (and prevent hypothermia). Therefore, the primary purpose of this investigation is to validate a body temperature alerting system using physiological responses that occur during rest, exercise in the heat and during body cooling. Multiple cooling modalities will be validated. This study is expanding on a previous intervention IRB#H20-0010 (BHSAI Cooling Study), but will examine body cooling during more intense exercise and while cycling. We will also examine the effectiveness of each cooling modality (passive cooling, mist-fan cooling, hand/forearm immersion, ice towel) on physiological variables after exercise in the heat.

Primary Outcome

Participants will be fitted with a Hans Rudolph mask attached to a breathing tube to measure the expired air delivered to the metabolic cart system during the exercise protocol. The metabolic cart will continuously measure oxygen consumption (VO2) to asess their VO2max value.

Conditions Studied

Interventions

  • OTHER Forearm coolng
  • OTHER Wet-towel cooling
  • OTHER mist-fan
  • OTHER passive cooling

Study Locations (1)

Connecticut

  • Korey Stringer Institute, University of Connecticut - Storrs

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2021-04-02
Est. Completion 2021-07-19
Phase NA
University of Connecticut

107 total trials

What the finished NCT04715711 record still lists

NCT04715711 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 49-participant average among 15 other Hyperthermia trials with a reported enrollment target (76% lower).

The record links to 1 condition, with Hyperthermia appearing as the primary indexed condition, and to 4 interventions - of which Forearm coolng is the first listed.

NCT04715711 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT04715711 about?

NCT04715711 is a clinical study titled "Physiological and Thermoregulatory Responses of Body Cooling During Cycling in a Hot Environment". BHSAI is developing a computational system that provides early alerts of a rise in core body temperature to help reduce the risk of heat injury in the field and during training. The goal of the body temperature alerting system is to use it during rest, exercise in the heat and during body cooling. U...

What is the current status of trial NCT04715711?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-04-02. Estimated completion is 2021-07-19.

What conditions does trial NCT04715711 study?

This clinical trial studies the following conditions: Hyperthermia.

What interventions are being tested in trial NCT04715711?

The interventions under investigation include: Forearm coolng (OTHER), Wet-towel cooling (OTHER), mist-fan (OTHER), passive cooling (OTHER).

Who is sponsoring clinical trial NCT04715711?

This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04715711 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hyperthermia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04715711's enrollment target sits among peer trials

12 12th of 15 higher than 1 of 15 other Hyperthermia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hyperthermia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04715711, the US trial registry maintained by the National Library of Medicine. NCT04715711 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.